Theracryf Plc (AIM:TCF)
London
· Delayed Price · Currency is GBP · Price in GBX 0.2250
0.00 (0.00%)
Apr 25, 2025, 4:35 PM GMT+1
Theracryf Revenue
In the fiscal year ending March 31, 2024, Theracryf had annual revenue of 396.00K GBP, down -10.41%.
Revenue
396.00K
Revenue Growth
-10.41%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
4.79M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |